Results 241 to 250 of about 213,003 (293)
Correction: Alveolar echinococcosis.
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekkeMogens, Jensenius +10 more
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hepatic Alveolar Echinococcosis
Seminars in Liver Disease, 2021AbstractHepatic alveolar echinococcosis (HAE) is a rare but severe zoonosis caused by the pseudotumoral intrahepatic development of the larval stage of the tapeworm Echinococcus multilocularis. HAE is present only in the Northern Hemisphere, predominantly in China.
Solange, Bresson-Hadni +2 more
openaire +3 more sources
Cerebral Alveolar Echinococcosis
New England Journal of Medicine, 2023Hu Ju, Chuanchuan Liu
openaire +3 more sources
Intracerebral Alveolar Echinococcosis
Infection, 2003There are two species of the genus Echinococcus, Echinococcus multilocularis (also called alveolar hydatid) and Echinococcus granulosus, characterized by distinct growth features in humans. The main endemic regions for human alveolar echinococcosis (AE) caused by E.
M-P, Algros +7 more
openaire +2 more sources
CT Imaging Findings of Pulmonary Alveolar Echinococcosis.
Current medical imaging, 2022Alveolar echinococcosis is a parasitic infection caused by Echinococcus multilocularis in the metacestode stage. The disease involves the liver in almost all cases, and additionally, lung involvement is accompanied in approximately 13% of the cases.
A. Eroğlu, H. Oğul, Y. Aydın
semanticscholar +1 more source
Antimicrobial Agents and Chemotherapy
Albendazole (ABZ) is the primary treatment for alveolar echinococcosis (AE); however, its limited solubility impacts oral bioavailability, affecting therapeutic outcomes. In this study, various ABZ-solubilizing formulations, including albendazole crystal
Chaoqun Li +5 more
semanticscholar +1 more source
Albendazole (ABZ) is the primary treatment for alveolar echinococcosis (AE); however, its limited solubility impacts oral bioavailability, affecting therapeutic outcomes. In this study, various ABZ-solubilizing formulations, including albendazole crystal
Chaoqun Li +5 more
semanticscholar +1 more source
HLA and alveolar echinococcosis
Tissue Antigens, 1998Abstract: Evidence in animal intermediate hosts that susceptibility to larval infection with Echinococcus multilocularis is restricted to individual host factors prompted us to investigate the susceptibility markers in humans. Because antigens of the extracellular parasite E multilocularis are possibly presented by MHC molecules in a restricted way ...
T H, Eiermann +10 more
openaire +2 more sources
Hepatic Alveolar Echinococcosis
Acta Radiologica, 1999Alveolar echinococcosis is a rare parasitic disease caused by Echinococcus multilocularis and most commonly involves the liver. Early diagnosis and precise evaluation of the localisation and the extent of the lesions are essential for treatment. In this report, we present US and CT findings in a patient with hepatic alveolar echinococcosis.
O, Akin, I, Isiklar
openaire +2 more sources
Revue medicale de Liege, 2006
Alveolar echinococcosis is a serious parasitic disease, leading to large hepatic lesions. It must be distinguished from cystic echinococcosis, or hydatic cyst, caused by Echinococcus granulosus. Early diagnosis may allow surgical removal of the lesions by segmental hepatectomy, the only curative treatment.
O, Wauters +12 more
openaire +1 more source
Alveolar echinococcosis is a serious parasitic disease, leading to large hepatic lesions. It must be distinguished from cystic echinococcosis, or hydatic cyst, caused by Echinococcus granulosus. Early diagnosis may allow surgical removal of the lesions by segmental hepatectomy, the only curative treatment.
O, Wauters +12 more
openaire +1 more source
Diffuse alveolar echinococcosis
Medicina Clínica, 2023Yener Aydin, Hayri Ogul, Suat Eren
openaire +2 more sources